Literature DB >> 17197448

Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.

Catherine M Radcliffe1, James N Arnold, David M Suter, Mark R Wormald, David J Harvey, Louise Royle, Yusuke Mimura, Yoshinobu Kimura, Robert B Sim, Susana Inogès, Mercedes Rodriguez-Calvillo, Natalia Zabalegui, Ascensión López-Díaz de Cerio, Kathleen N Potter, C Ian Mockridge, Raymond A Dwek, Maurizio Bendandi, Pauline M Rudd, Freda K Stevenson.   

Abstract

Expression of surface immunoglobulin appears critical for the growth and survival of B-cell lymphomas. In follicular lymphoma, we found previously that the Ig variable (V) regions in the B-cell receptor express a strikingly high incidence of N-glycosylation sequons, NX(S/T). These potential glycosylation sites are introduced by somatic mutation and are lymphoma-specific, pointing to their involvement in tumor pathogenesis. Analysis of the V region sugars from lymphoma-derived IgG/IgM reveals that they are mostly oligomannose and, remarkably, are located in the antigen-binding site, possibly precluding conventional antigen binding. The Fc region contains complex glycans, confirming that the normal glycan processing pathway is intact. Binding studies indicate that the oligomannose glycans occupying the V regions are accessible to mannose-binding lectin. These findings suggest a potential contribution to lymphoma pathogenesis involving antigen-independent interaction of surface immunoglobulin of the B-cell receptor with mannose-binding molecules of innate immunity in the germinal center.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17197448     DOI: 10.1074/jbc.M602690200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations.

Authors:  Yu-Chang Wu; David Kipling; Hui Sun Leong; Victoria Martin; Alexander A Ademokun; Deborah K Dunn-Walters
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

3.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

4.  Tumor cells express pauci- and oligomannosidic N-glycans in glycoproteins recognized by the mannose receptor (CD206).

Authors:  Kathrin Stavenhagen; Lisa C Laan; Chao Gao; Akul Y Mehta; Jamie Heimburg-Molinaro; Jonathan N Glickman; Irma van Die; Richard D Cummings
Journal:  Cell Mol Life Sci       Date:  2021-06-05       Impact factor: 9.261

5.  Origin and migration of follicular lymphoma cells.

Authors:  Philip M Kluin
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

Review 6.  The microenvironment in mature B-cell malignancies: a target for new treatment strategies.

Authors:  Jan A Burger; Paolo Ghia; Andreas Rosenwald; Federico Caligaris-Cappio
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

Review 7.  Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures.

Authors:  Maurizio Bendandi
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

8.  Genomic and epigenomic co-evolution in follicular lymphomas.

Authors:  M Loeffler; M Kreuz; A Haake; D Hasenclever; H Trautmann; C Arnold; K Winter; K Koch; W Klapper; R Scholtysik; M Rosolowski; S Hoffmann; O Ammerpohl; M Szczepanowski; D Herrmann; R Küppers; C Pott; R Siebert
Journal:  Leukemia       Date:  2014-07-16       Impact factor: 11.528

9.  Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses.

Authors:  Susana Inoges; Ascension Lopez-Diaz de Cerio; Helena Villanueva; Fernando Pastor; Elena Soria; Maurizio Bendandi
Journal:  World J Clin Oncol       Date:  2011-06-10

Review 10.  Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.

Authors:  Ryan M Young; James D Phelan; Wyndham H Wilson; Louis M Staudt
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.